Group One Trading
INO icon

Group One Trading’s Inovio Pharmaceuticals INO Stock Holding History

Group One Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165K Sell
94,700
-148,900
-61% -$245K ﹤0.01% 4284
2025
Q4 		$424K Sell
243,600
-91,400
-27% -$201K ﹤0.01% 3685
2025
Q3 		$784K Sell
335,000
-29,200
-8% -$55.9K ﹤0.01% 3267
2025
Q2 		$741K Buy
364,200
+122,800
+51% +$235K ﹤0.01% 3040
2025
Q1 		$393K Buy
241,400
+220,000
+1,028% +$441K ﹤0.01% 3336
2024
Q4 		$39.2K Sell
21,400
-2,900
-12% -$12.8K ﹤0.01% 5237
2024
Q3 		$140K Buy
24,300
+3,900
+19% +$32.2K ﹤0.01% 3913
2024
Q2 		$165K Sell
20,400
-4,000
-16% -$42.1K ﹤0.01% 3558
2024
Q1 		$339K Buy
24,400
+24,117
+8,522% +$208K ﹤0.01% 3107
2023
Q4 		$1.73K Sell
283
-134
-32% -$661 ﹤0.01% 6863
2023
Q3 		$1.95K Sell
417
-583
-58% -$3.22K ﹤0.01% 7049
2023
Q2 		$5.36K Sell
1,000
-2,400
-71% -$19.3K ﹤0.01% 6686
2023
Q1 		$33.5K Sell
3,400
-2,600
-43% -$44.3K ﹤0.01% 5162
2022
Q4 		$112K Sell
6,000
-2,900
-33% -$65.7K ﹤0.01% 4333
2022
Q3 		$184K Sell
8,900
-692
-7% -$17.7K ﹤0.01% 4227
2022
Q2 		$199K Sell
9,592
-7,233
-43% -$204K ﹤0.01% 4311
2022
Q1 		$725K Sell
16,825
-22,542
-57% -$1.02M ﹤0.01% 3423
2021
Q4 		$2.36M Sell
39,367
-11,666
-23% -$935K ﹤0.01% 2415
2021
Q3 		$4.38M Buy
51,033
+3,833
+8% +$385K ﹤0.01% 1838
2021
Q2 		$5.25M Sell
47,200
-2,683
-5% -$258K 0.01% 1645
2021
Q1 		$5.55M Sell
49,883
-1,400
-3% -$184K 0.01% 1423
2020
Q4 		$5.45M Sell
51,283
-52,475
-51% -$6.99M 0.01% 1206
2020
Q3 		$14.4M Buy
103,758
+18,400
+22% +$3.84M 0.05% 377
2020
Q2 		$27.6M Sell
85,358
-25,350
-23% -$4.07M 0.13% 143
2020
Q1 		$9.88M Buy
110,708
+109,325
+7,905% +$6.74M 0.08% 257
2019
Q4 		$55K Buy
1,383
+883
+177% +$26.6K ﹤0.01% 3964
2019
Q3 		$12K Sell
500
-3,233
-87% -$98.3K ﹤0.01% 4538
2019
Q2 		$132K Buy
3,733
+2,800
+300% +$111K ﹤0.01% 3139
2019
Q1 		$42K Sell
933
-1,675
-64% -$84.4K ﹤0.01% 3648
2018
Q4 		$125K Buy
2,608
+541
+26% +$32.9K ﹤0.01% 3032
2018
Q3 		$138K Buy
2,067
+592
+40% +$33K ﹤0.01% 3284
2018
Q2 		$69K Sell
1,475
-2,600
-64% -$143K ﹤0.01% 3773
2018
Q1 		$230K Buy
4,075
+1,575
+63% +$85.2K ﹤0.01% 2680
2017
Q4 		$124K Sell
2,500
-9,708
-80% -$602K ﹤0.01% 3233
2017
Q3 		$929K Buy
12,208
+10,475
+604% +$779K 0.01% 1617
2017
Q2 		$163K Buy
1,733
+1,066
+160% +$91.2K ﹤0.01% 2795
2017
Q1 		$53K Sell
667
-24,975
-97% -$1.99M ﹤0.01% 3365
2016
Q4 		$2.13M Sell
25,642
-2,050
-7% -$185K 0.02% 885
2016
Q3 		$3.1M Sell
27,692
-1,341
-5% -$148K 0.03% 621
2016
Q2 		$3.22M Buy
29,033
+12,783
+79% +$1.55M 0.04% 574
2016
Q1 		$1.7M Buy
16,250
+12,383
+320% +$956K 0.02% 867
2015
Q4 		$312K Sell
3,867
-1,516
-28% -$121K ﹤0.01% 2170
2015
Q3 		$373K Buy
5,383
+1,283
+31% +$112K 0.01% 2013
2015
Q2 		$401K Buy
4,100
+958
+30% +$102K 0.01% 1978
2015
Q1 		$308K Sell
3,142
-9,175
-74% -$889K ﹤0.01% 2011
2014
Q4 		$1.36M Sell
12,317
-15,966
-56% -$1.95M 0.02% 867
2014
Q3 		$3.34M Buy
28,283
+12,533
+80% +$1.56M 0.05% 441
2014
Q2 		$2.04M Buy
15,750
+11,758
+295% +$1.39M 0.03% 677
2014
Q1 		$638K Buy
+3,992
New +$573K 0.01% 1450

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's INO Position: Q2 2025 in Review

Group One Trading sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 2,924 shares — an estimated $5.6K sold.

Group One Trading first reported a position in INO in Q1 2014 and held it in 30 quarters. The position peaked at $1.04M in Q2 2015. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Group One Trading reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 2,924 Inovio Pharmaceuticals shares in Q2 2025, an estimated $5.6K.
  • Group One Trading first reported a position in Inovio Pharmaceuticals in Q1 2014 and held it in 30 quarters.
  • Group One Trading's Inovio Pharmaceuticals position peaked at $1.04M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.